ProfileGDS4718 / 1554033_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 17% 22% 23% 30% 21% 27% 19% 24% 22% 21% 21% 18% 26% 22% 29% 23% 18% 22% 19% 29% 22% 20% 24% 23% 23% 21% 21% 16% 28% 29% 21% 22% 21% 18% 23% 21% 25% 19% 24% 20% 20% 23% 24% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1016618
GSM549102patient 115, normal, homogenized [OPG study]4.0585117
GSM549104patient 119, normal, homogenized [OPG study]4.2188922
GSM549108patient 138, normal, homogenized [OPG study]4.3034523
GSM549119patient 077, normal, homogenized [OPG study]4.5323430
GSM549133patient 032, cancer, homogenized [OPG study]4.1176921
GSM549139patient 042, cancer, homogenized [OPG study]4.4042227
GSM549099patient 107, normal, homogenized [OPG study]4.1300519
GSM549109patient 139, normal, homogenized [OPG study]4.3175624
GSM549110patient 046, normal, homogenized [OPG study]4.2379422
GSM549114patient 063, normal, homogenized [OPG study]4.1580421
GSM549122patient 082, normal, homogenized [OPG study]4.1869421
GSM549134patient 033, cancer, homogenized [OPG study]4.0533518
GSM549136patient 036, cancer, homogenized [OPG study]4.3141126
GSM549140patient 044, cancer, homogenized [OPG study]4.1898722
GSM549111patient 047, normal, homogenized [OPG study]4.4652129
GSM549113patient 057, normal, homogenized [OPG study]4.2050723
GSM549132patient 031, cancer, homogenized [OPG study]4.0760418
GSM549137patient 038, cancer, homogenized [OPG study]4.1968822
GSM549142patient 047, cancer, homogenized [OPG study]4.1999319
GSM549100patient 110, normal, homogenized [OPG study]4.5120729
GSM549107patient 135, normal, homogenized [OPG study]4.1838122
GSM549115patient 068, normal, homogenized [OPG study]4.0949920
GSM549116patient 072, normal, homogenized [OPG study]4.2640424
GSM549120patient 078, normal, homogenized [OPG study]4.2717123
GSM549131patient 030, cancer, homogenized [OPG study]4.2000623
GSM549118patient 074, normal, homogenized [OPG study]4.1935121
GSM549129patient 027, cancer, homogenized [OPG study]4.1887921
GSM549123patient 088, normal, homogenized [OPG study]4.008216
GSM549124patient 006, cancer, homogenized [OPG study]4.4907628
GSM549126patient 015, cancer, homogenized [OPG study]4.5027829
GSM549128patient 025, cancer, homogenized [OPG study]4.1580421
GSM549103patient 117, normal, homogenized [OPG study]4.2531922
GSM549117patient 073, normal, homogenized [OPG study]4.1776221
GSM549138patient 041, cancer, homogenized [OPG study]4.0538118
GSM549141patient 045, cancer, homogenized [OPG study]4.2002723
GSM549130patient 028, cancer, homogenized [OPG study]4.1892921
GSM549101patient 111, normal, homogenized [OPG study]4.350425
GSM549105patient 128, normal, homogenized [OPG study]4.1068819
GSM549106patient 134, normal, homogenized [OPG study]4.2385524
GSM549112patient 048, normal, homogenized [OPG study]4.1381320
GSM549125patient 011, cancer, homogenized [OPG study]4.1749320
GSM549127patient 024, cancer, homogenized [OPG study]4.2423723
GSM549135patient 035, cancer, homogenized [OPG study]4.2517624